3.54 USD
↗ 0.04 (1.14%)AT CLOSE (11:59 AM EDT)
Rocket Pharmaceuticals, Inc. Common Stock
RCKTNASDAQ • USD
3.57
↗ 0.02 (0.71%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
3.57
↗ 0.02 (0.71%)
Market: CLOSED
Rocket Pharmaceuticals, Inc. Common Stock (RCKT) trades at $3.52 per share. RCKT shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 6, 2026.
Open?$3.52
High?$3.62
Low?$3.49
Prev. Close?$3.50
Volume?2.1M
Avg. Volume?2.1M
VWAP?$3.54
Rel. Volume?1.02x
Bid / Ask
Bid?$3.40 × 1.0K
Ask?$3.55 × 2.5K
Spread?$0.15
Midpoint?$3.47
Valuation & Ratios
Market Cap?382.2M
Shares Out?109.2M
Float?84.6M
Float %?77.5%
P/E Ratio?N/A
P/B Ratio?1.61
EPS?-$1.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Themes
Employees
202
Market Cap
382.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-02-18
Address
350 FIFTH AVENUE
NEW YORK, NY 10118
Phone: 646-440-9100
NEW YORK, NY 10118
Phone: 646-440-9100
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?50
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.43Distress
Confidence?56%Low
Short InterestHigh
Short % of Float?19.59%High
Short Interest?16.6M
Days to Cover?6.8
Free Float84.6M
Avg Daily Volume2.4M
Settlement Date2026-07-15
Financial Health
Current Ratio?6.12Strong
Quick Ratio?6.12Strong
Cash Ratio?2.03Strong
Debt/Equity?0.09Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.61CHEAP▾
Peers100
S&P84
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-88.0%WEAK▾
S&P3
ROA?-73.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-179787000
Enterprise Value?$353.8M
Fundamentals ratios updated end of day